Sprayable gel for postsurgical immunotherapy
Immuno-Oncology and Technology · 2019
DOI: 10.1016/j.iotech.2019.07.001 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Immuno-Oncology and Technology, 2019. Verfasst von Qian Chen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Functional Nano and Soft Materials, Jiangsu Key Laboratory for Carbon-Based Functional Materials and Devices, Soochow University, Jiangs…. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Collaborative Innovation Center of Suzhou Nano Science and Technology, University of California, Los Angeles, Higher Education Discipline Innovation Project.
Abstract (Originalsprache)
Background
Surgery remains the first option to treat most solid tumors. However, despite the development of surgical techniques, the elimination of tumor recurrence after surgery remains a challenge.
Design
In a recent study published in Nature Nanotechnology, we described an in-situ-sprayed gel for local delivery of bioresponsive and immunotherapeutic calcium carbonate nanoparticles encapsulated with anti-CD47 antibodies (aCD47@CaCO3) to the surgical site after surgery. CaCO3 nanoparticles react with H+ in the surgical wound site, eliciting an immunosupportive tumor microenvironment after surgery. Meanwhile, the subsequently released aCD47 blocks the 'don't eat me' signal expressed on cancer cells to increase the phagocytosis of cancer cells by macrophages and activate T-cell-mediated antitumor immune responses.
Conclusion
The engineered immunotherapeutic gel could activate both innate and adaptive immune responses systemically after local treatment, effectively destroying the remaining cancer cells and reducing tumor recurrence.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Functional Nano and Soft Materials, Jiangsu Key Laboratory for Carbon-Based Functional Materials and Devices, Soochow University, Jiangsu, PR China.
- Department of Bioengineering, University of California, Los Angeles, USA.
- California NanoSystems Institute, University of California, Los Angeles, USA.
- Jonsson Comprehensive Cancer Center, University of California, Los Angeles, USA.
- Center for Minimally Invasive Therapeutics, University of California, Los Angeles, USA.
Förderung
- Collaborative Innovation Center of Suzhou Nano Science and Technology
- University of California, Los Angeles
- Higher Education Discipline Innovation Project
- Jonsson Comprehensive Cancer Center
- Alfred P. Sloan Foundation
- Priority Academic Program Development of Jiangsu Higher Education Institutions
Zitieren
APA
Chen, Q., Ci, T., & Gu, Z. (2019). Sprayable gel for postsurgical immunotherapy. Immuno-Oncology and Technology. https://doi.org/10.1016/j.iotech.2019.07.001
Vancouver
Chen Q, Ci T, Gu Z. Sprayable gel for postsurgical immunotherapy. Immuno-Oncology and Technology. 2019. doi:10.1016/j.iotech.2019.07.001
BibTeX
@article{Chen2019,
author = {Chen, Qian and Ci, Tianyuan and Gu, Zhen},
title = {Sprayable gel for postsurgical immunotherapy},
journal = {Immuno-Oncology and Technology},
year = {2019},
doi = {10.1016/j.iotech.2019.07.001}
}
EUVIMED